Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Reinhardt

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
NPJ Parkinson'S Disease|April 10, 2019
Modeling Parkinson's disease in midbrain-like organoidsLisa M Smits, Lydia Reinhardt, Peter Reinhardt, et al.
Journal of Medicinal Chemistry|April 2, 2019
Fragment-Based Discovery of an Apolipoprotein E4 (apoE4) StabilizerAndrew M Petros, Alla Korepanova, Clarissa G Jakob, et al.
Human Molecular Genetics|November 26, 2013
Human iPSC models of neuronal ceroid lipofuscinosis capture distinct effects of TPP1 and CLN3 mutations on the endocytic pathwayXenia Lojewski, John F Staropoli, Sunita Biswas-Legrand, et al.
Stem Cell Reports|June 20, 2025
BMP, MEK, and WNT inhibition with NGN2 expression for rapid generation of hiPSC-derived neurons amenable to regional patterningCarina Habich, Alexandra Kowalski, Astrid Wachter, et al.
Cell Chemical Biology|February 4, 2018
Dynarrestin, a Novel Inhibitor of Cytoplasmic DyneinSusanne Höing, Ting-Yu Yeh, Matthias Baumann, et al.
Stem Cell Reports|February 19, 2019
Dual Inhibition of GSK3β and CDK5 Protects the Cytoskeleton of Neurons from Neuroinflammatory-Mediated Degeneration In Vitro and In VivoLydia Reinhardt, Susanne Kordes, Peter Reinhardt, et al.
Cell Stem Cell|March 12, 2013
Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expressionPeter Reinhardt, Benjamin Schmid, Lena F Burbulla, et al.
Nature Communications|January 25, 2018
Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formationMarcel Naumann, Arun Pal, Anand Goswami, et al.
Acta Neuropathologica Communications|May 19, 2025
hiPSC-neurons recapitulate the subtype-specific cell intrinsic nature of susceptibility to neurodegenerative disease-relevant aggregationIan Weidling, Christina N Preiss, Sarah E Chancellor, et al.
Stem Cell Reports|September 25, 2018
Reproducibility of Molecular Phenotypes after Long-Term Differentiation to Human iPSC-Derived Neurons: A Multi-Site Omics StudyViola Volpato, James Smith, Cynthia Sandor, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
NPJ Parkinson'S Disease|April 10, 2019
Modeling Parkinson's disease in midbrain-like organoidsLisa M Smits, Lydia Reinhardt, Peter Reinhardt, et al.
Journal of Medicinal Chemistry|April 2, 2019
Fragment-Based Discovery of an Apolipoprotein E4 (apoE4) StabilizerAndrew M Petros, Alla Korepanova, Clarissa G Jakob, et al.
Human Molecular Genetics|November 26, 2013
Human iPSC models of neuronal ceroid lipofuscinosis capture distinct effects of TPP1 and CLN3 mutations on the endocytic pathwayXenia Lojewski, John F Staropoli, Sunita Biswas-Legrand, et al.
Stem Cell Reports|June 20, 2025
BMP, MEK, and WNT inhibition with NGN2 expression for rapid generation of hiPSC-derived neurons amenable to regional patterningCarina Habich, Alexandra Kowalski, Astrid Wachter, et al.
Cell Chemical Biology|February 4, 2018
Dynarrestin, a Novel Inhibitor of Cytoplasmic DyneinSusanne Höing, Ting-Yu Yeh, Matthias Baumann, et al.
Stem Cell Reports|February 19, 2019
Dual Inhibition of GSK3β and CDK5 Protects the Cytoskeleton of Neurons from Neuroinflammatory-Mediated Degeneration In Vitro and In VivoLydia Reinhardt, Susanne Kordes, Peter Reinhardt, et al.
Cell Stem Cell|March 12, 2013
Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expressionPeter Reinhardt, Benjamin Schmid, Lena F Burbulla, et al.
Nature Communications|January 25, 2018
Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formationMarcel Naumann, Arun Pal, Anand Goswami, et al.
Acta Neuropathologica Communications|May 19, 2025
hiPSC-neurons recapitulate the subtype-specific cell intrinsic nature of susceptibility to neurodegenerative disease-relevant aggregationIan Weidling, Christina N Preiss, Sarah E Chancellor, et al.
Stem Cell Reports|September 25, 2018
Reproducibility of Molecular Phenotypes after Long-Term Differentiation to Human iPSC-Derived Neurons: A Multi-Site Omics StudyViola Volpato, James Smith, Cynthia Sandor, et al.
Pageof 8